Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
9.41
-0.02 (-0.21%)
At close: Nov 26, 2025, 4:00 PM EST
9.30
-0.11 (-1.17%)
After-hours: Nov 26, 2025, 6:38 PM EST

DAWN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
9661,2781,2711,5831,044-
Upgrade
Market Cap Growth
-41.55%0.54%-19.71%51.68%--
Upgrade
Enterprise Value
5177228661,209747-
Upgrade
Last Close Price
9.4112.6714.6021.5216.85-
Upgrade
PS Ratio
7.249.74----
Upgrade
PB Ratio
2.142.543.674.773.71-
Upgrade
P/TBV Ratio
2.242.623.674.773.71-
Upgrade
EV/Sales Ratio
3.875.50----
Upgrade
Debt / Equity Ratio
0.010.010.000.000.000.01
Upgrade
Asset Turnover
0.240.27----
Upgrade
Quick Ratio
8.297.4312.4220.6032.8421.91
Upgrade
Current Ratio
8.687.6612.7220.9433.4322.58
Upgrade
Return on Equity (ROE)
-30.16%-22.49%-55.68%-46.37%-44.83%-127.49%
Upgrade
Return on Assets (ROA)
-18.57%-27.67%-35.52%-28.74%-27.10%-23.60%
Upgrade
Return on Capital (ROIC)
-20.46%-31.13%-37.89%-29.90%-27.96%-24.90%
Upgrade
Return on Capital Employed (ROCE)
-36.20%-41.70%-59.50%-44.20%-25.90%-31.60%
Upgrade
Earnings Yield
-15.71%-7.47%-14.87%-8.98%-6.77%-
Upgrade
FCF Yield
-12.56%-6.28%-11.57%-6.94%-4.65%-
Upgrade
Buyback Yield / Dilution
-15.45%-16.87%-21.85%-77.13%-568.42%6.67%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q